To construct pLV/AAVS1-donor-fluc-PGK and pLV/AAVS1-donor-egfp-PGK, inserts were amplified from pLV/fluc-PGK-PBT (Cai et al., 2014b) and pLV/egfp-PGK-PBT (cloned similarly as pLV/fluc-PGK-PBT), respectively, using primer sets YJ219F-YJ210R (primers are listed in Supplementary file 2A). The inserts were subsequently digested by BsiWI/SalI and cloned into pLV/AAVS1-donor-LS (Cai et al., 2014a) that was digested with the same pair of enzymes. pLV/AAVS1-donor-puro-PGK and pLV/CCR5-donor-puro-PGK were cloned similarly by amplifying inserts from pLV/puro-PGK-PBT using primer set YJ262F-YJ210R and ligated with pLV/AAVS1-donor-LS and pLV/CCR5-donor-LS (Cai et al., 2014b), respectively. Restriction enzymes used for inserts and vectors were BsrGI/SalI and BsiWI/SalI, respectively. All donor sequences are provided in Supplementary file 3. The packaging construct, pMDlg/pRRE-D64V-218, for production of IDLVs was constructed by introducing a D64V mutation into the integrase of pMDlg/pRRE by overlap PCR. For the first round PCR, primers AgeI-int(s)-int-D64V(as) and int-D64V(s)-AccIII-int(as) were used, respectively, with pMDlg/pRRE as the templates. For the second round PCR, primers AgeI-int(s) and AccIII-int(as) were used with the PCR product from the first round as template. The inserts and vector pMDlg/pRRE were then both digested by AgeI and AccIII before ligation.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.